抗がん剤としての腫瘍ウイルス:臨床的進展と残る課題
Elizabeth Appleton1, E Antonio Chiocca2, Guy Ungerechts3
1Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK; Department of Life Sciences, Imperial College London, London, United Kingdom; Department of Molecular Medicine Mayo Clinic, Rochester, MN, USA.
Lancet (London, England)
|September 20, 2025
まとめ
腫瘍解毒ウイルスは 腫瘍を破壊し 免疫系を活性化することで 癌治療の有望性を示しています 臨床翻訳の課題を克服することは 患者の利益のために 潜在力を発揮する鍵です
科学分野:
- 腫瘍学
- 免疫学
- ウイルス学
背景:
- 免疫療法は 癌治療に革命をもたらしましたが 患者の反応や抵抗に 課題があります
- 腫瘍解毒ウイルスは 選択的に癌細胞を破壊し 腫瘍の微小環境を調整するように設計されています
- がん免疫学とウイルス工学の進歩により,腫瘍解毒ウイルス治療への関心が高まっています.
研究 の 目的:
- 腫瘍解毒ウイルスの臨床開発における重要なマイルストーンをレビューする.
- 広範な臨床実施を阻害する持続的な課題について議論する.
- 患者の利益のために 合理化された将来の研究方向を提案する.
主な方法:
- 腫瘍解毒ウイルスの臨床開発のマイルストーンのレビュー
- 腫瘍解毒ウイルス療法における現在の課題の分析
- 将来の研究戦略を導くための臨床的反省
主要な成果:
- 腫瘍性ウイルスは,がん細胞を選択的に標的にし,抗腫瘍免疫を強化する能力を示しています.
- 臨床前と早期の臨床データが有望であるにも関わらず,広範な採用を妨げている大きな障壁があります.
- 開発の重要なマイルストーンは達成されましたが,臨床翻訳は遅れています.
結論:
- 腫瘍解毒ウイルス療法は ウイルスの複製と免疫刺激を活用することで 癌の治療に有意義な可能性を秘めています
- 臨床翻訳,製造,配送の課題に取り組むことが成功に不可欠です.
- 研究開発の取り組みを簡素化することで 患者の有意義な利益への道を加速できます
関連する概念動画
01:30Cancer Vaccines
974
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
974
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
01:27Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
01:51Mechanisms of Retrovirus-induced Cancers
6.9K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.9K
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K